Main content

Supplementary Figures for Rapamycin Radiation Response

Show full item record

Title: Supplementary Figures for Rapamycin Radiation Response
Author: Phan, Morla; Kim, Changseok; Mutsaers, Anthony; Poirier, Valerie; Coomber, Brenda
Department: Department of Biomedical Sciences
Abstract: Rapamycin has been reported to reduce cancer cell survival in certain tumors following radiation therapy, but the mechanisms driving this phenomenon are unclear. Rapamycin inhibits mTOR signaling, a pathway responsible for several essential cell functions. The objective of this study was to investigate the effects of rapamycin and radiation on the activation and inhibition of mTOR signaling and the relationship between mTOR signaling and DNA damage response in vitro using canine mast cell tumor (MCT) cancer cell lines. Rapamycin rapidly inhibited S6K phosphorylation in a dose-dependent manner. Ionizing radiation (3, 6, or 10 Gy) was able to activate mTOR signalling, but the combination of radiation and rapamycin maintained mTOR inhibition. The comet assay revealed that co-treatment with rapamycin induced modest increases in the severity of DNA damage to MCT cells, but that these differences were not statistically significant. Although the relationship between mTOR and DNA damage response in MCT cancer cell lines remains unclear, our findings suggest the possibility of interaction, leading to enhancement of radiation response.
Date: 2021
Terms of Use: All items in the Atrium are protected by copyright with all rights reserved unless otherwise indicated.
Related Publications: Phan M, Kim C, Mutsaers A, Poirier V, Coomber B. Modulation of mTOR signaling by radiation and rapamycin treatment in canine mast cell cancer cells. Can J Vet Res. 2022 Jan;86(1):3-12

Files in this item

Files Size Format View
Supplementary_Figures.pdf 1.732Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record